Ovarian Cancer
Ovarian cancer is a silent killer; however, recent improvements in identification of women at high risk for ovarian cancer, as well as improved imaging techniques, increase the likelihood of early detection. Ovarian cancer is the most deadly gynecologic malignancy, with an overall survival rate of approximately 35%. No specific signs or symptoms are observed in ovarian cancer. Investigations are Complete blood count (CBC) Blood chemistry, CA125-a blood test used to monitor the progress and treatment of cancer, particularly ovarian cancer, Quantitative serum hCG (blood pregnancy test) Alpha fetoprotein Urinalysis Pelvic sonography is the examination of choice, followed by MRI and/or CT. When ovarian cancer is suspected, patients usually undergo an exploratory laparotomy to determine the stage of the disease (i.e. how far it has spread). During exploratory laparotomy, the physician (usually a gynecologic oncologist) makes an incision through the abdomen to the ovaries according to the TNM system. Surgery should be performed in women who have finished childbearing. This includes total hysterectomy, complete removal of the uterus; bilateral salpingo-oophorectomy, removal of the fallopian tubes and ovaries; omentectomy, removal of the fatty tissue that covers the bowels; and lymphadenectomy, removal of one or more lymph nodes. Yet results from a patient's histopathology report may suggest additional care, such as Radiotherapy plus chemotherapy, Combination chemotherapy.
In order to proceed further, you need to have an account on IDG.
Create a new account now
Registered users, you can login below to access this page.
Browse more articles in Tumours